ZA911886B - Synthetic polypeptides - Google Patents

Synthetic polypeptides

Info

Publication number
ZA911886B
ZA911886B ZA911886A ZA911886A ZA911886B ZA 911886 B ZA911886 B ZA 911886B ZA 911886 A ZA911886 A ZA 911886A ZA 911886 A ZA911886 A ZA 911886A ZA 911886 B ZA911886 B ZA 911886B
Authority
ZA
South Africa
Prior art keywords
synthetic polypeptides
polypeptides
synthetic
Prior art date
Application number
ZA911886A
Inventor
Robert V Fishleigh
V Fishleigh Robert
Barry Robson
Robson Barry
Original Assignee
Proteus Molecular Design
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteus Molecular Design filed Critical Proteus Molecular Design
Publication of ZA911886B publication Critical patent/ZA911886B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA911886A 1990-03-15 1991-03-14 Synthetic polypeptides ZA911886B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909005829A GB9005829D0 (en) 1990-03-15 1990-03-15 Synthetic polypeptides

Publications (1)

Publication Number Publication Date
ZA911886B true ZA911886B (en) 1991-12-24

Family

ID=10672665

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA911886A ZA911886B (en) 1990-03-15 1991-03-14 Synthetic polypeptides

Country Status (17)

Country Link
EP (1) EP0519986A1 (en)
JP (1) JPH05505188A (en)
CN (1) CN1054772A (en)
AP (1) AP211A (en)
AU (1) AU636735B2 (en)
BR (1) BR9106159A (en)
CA (1) CA2078220A1 (en)
CS (1) CS68091A2 (en)
FI (1) FI923800A0 (en)
GB (1) GB9005829D0 (en)
HU (1) HUT63179A (en)
IL (1) IL97551A0 (en)
MX (1) MX24890A (en)
NZ (1) NZ237417A (en)
OA (1) OA09671A (en)
WO (1) WO1991013909A1 (en)
ZA (1) ZA911886B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0565704A4 (en) * 1991-11-04 1995-10-25 Baxter Diagnostics Inc Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US5395750A (en) * 1992-02-28 1995-03-07 Hoffmann-La Roche Inc. Methods for producing proteins which bind to predetermined antigens
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
CA2130754C (en) * 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
ATE253050T1 (en) 1992-03-11 2003-11-15 Narhex Ltd AMINE DERIVATIVES OF OXO- AND HYDROXY-SUBSTITUTED HYDROCARBONS
GB9208428D0 (en) * 1992-04-16 1992-06-03 Proteus Molecular Design Synthetic polypeptides
US6511845B1 (en) 1992-08-07 2003-01-28 Alan R. Davis Methods for producing an immune response against HIV-1
CN1091138A (en) 1992-08-27 1994-08-24 迪金研究有限公司 Vaccine
DE4402756A1 (en) * 1994-01-31 1995-08-03 Boehringer Mannheim Gmbh Specific binding substances for antibodies and their use for immunoassays or vaccines
AUPM411994A0 (en) * 1994-02-25 1994-03-24 Deakin Research Limited Epitopes
US6764682B1 (en) * 1994-06-16 2004-07-20 Aventis Pasteur Limited Adjuvant compositions containing more than one adjuvant
US6290971B1 (en) 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
CN1472314A (en) * 2002-07-29 2004-02-04 清华大学 Immunity expression of AIDS virus O and its use
CN100445296C (en) * 2006-03-31 2008-12-24 浙江大学 Polypeptide organic compounds and application in xenogeneic transplantation
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
GB201612108D0 (en) 2016-07-12 2016-08-24 Univ Strathclyde Preperation of non-ionic surfactant vesicles and variants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
ES2054769T3 (en) * 1987-11-16 1994-08-16 Hoffmann La Roche RECOMBINANT HIV-2 POLYPEPTIDES.

Also Published As

Publication number Publication date
HUT63179A (en) 1993-07-28
CA2078220A1 (en) 1991-09-16
FI923800A (en) 1992-08-24
CS68091A2 (en) 1991-12-17
GB9005829D0 (en) 1990-05-09
AU636735B2 (en) 1993-05-06
AP211A (en) 1992-10-21
MX24890A (en) 1993-12-01
JPH05505188A (en) 1993-08-05
HU9202939D0 (en) 1992-12-28
CN1054772A (en) 1991-09-25
AU7467991A (en) 1991-10-10
AP9100245A0 (en) 1991-04-30
IL97551A0 (en) 1992-06-21
FI923800A0 (en) 1992-08-24
OA09671A (en) 1993-05-15
NZ237417A (en) 1993-10-26
EP0519986A1 (en) 1992-12-30
BR9106159A (en) 1993-03-16
WO1991013909A1 (en) 1991-09-19

Similar Documents

Publication Publication Date Title
IL95071A (en) Synthetic material-bottle
AP9100245A0 (en) Synthetic polypeptides
GB9208428D0 (en) Synthetic polypeptides
EP0447133A3 (en) Paired polypeptides
GB9016810D0 (en) Peptides
ZW9093A1 (en) Synthetic polypeptides
GB9125747D0 (en) Synthetic polypeptides
GB9106674D0 (en) Synthetic polypeptides
MW891A1 (en) Polypeptides
ZM1991A1 (en) Polypeptides
GB9016215D0 (en) Polypeptides
GB9219710D0 (en) Synthetic polypeptides
GB9215514D0 (en) Synthetic polypeptides
GB9214663D0 (en) Synthetic polypeptides
GB9218163D0 (en) Synthetic polypeptides
IE892648L (en) Synthetic polypeptides
ZA914206B (en) Crystalline polypeptides
GB9105871D0 (en) Synthetic peptides
GB8816991D0 (en) Synthetic polypeptides
GB8804657D0 (en) Synthetic polypeptides
GB8816988D0 (en) Synthetic polypeptides
GB8804655D0 (en) Synthetic polypeptides
GB8816989D0 (en) Synthetic polypeptides
GB8816990D0 (en) Synthetic polypeptides
GB8804658D0 (en) Synthetic polypeptides